<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03243591</url>
  </required_header>
  <id_info>
    <org_study_id>388-17-EP</org_study_id>
    <nct_id>NCT03243591</nct_id>
  </id_info>
  <brief_title>Impact of Oral Hygiene Gels on Peri-implant Mucositis</brief_title>
  <official_title>Impact of Oral Hygiene Gels on Peri-implant Mucositis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peri-implant mucositis is abnormal inflammation occurring around dental implants, increasing&#xD;
      the risk of loss of bone support. The purpose of this study is to evaluate the impact of&#xD;
      brushing the bacterial biofilm at the implant-mucosa interface with one of two,&#xD;
      commercially-available dental gels over a 30-day period on amounts of biofilm and indices of&#xD;
      mucosal inflammation. Adult subjects (&gt; 19 years old) will be invited to consent if they have&#xD;
      at least one dental implant displaying mucositis defined as Gingivitis Index of 2 or greater,&#xD;
      no dental treatment in the previous 30 days, capable of normal toothbrushing, and no Sjogrens&#xD;
      disease, immunodeficiency, pregnancy, poorly-controlled diabetes, or regular systemic&#xD;
      antibiotics, anti-inflammatory drugs or immune suppressants. Ten patients in each tooth gel&#xD;
      group will be instructed to apply a pea size amount of dentifrice brushing the implant and&#xD;
      mucosa 2 times daily for 30 days. Baseline and 30-day examinations will be conducted to&#xD;
      record Gingivitis Index, Plaque Index, probing depths, clinical photo, crevicular fluid, and&#xD;
      adverse events.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective, randomized, controlled, double-blind, single center study. Once&#xD;
      eligibility has been determined, up to 21 Subjects will be enrolled. Subjects will be&#xD;
      randomly assigned in a 1:1 ratio to treat with either Livionex Dental Gel (a plaque control&#xD;
      gel that is safe for ingestion and is currently sold by Livionex Inc.) or the control&#xD;
      Aquafresh toothpaste. Each study visit will last 30 minutes.&#xD;
&#xD;
      The soft tissue around the dental implant will be observed at baseline and after 30 days for&#xD;
      inflammation using the Gingivitis Index and probed with a UNC 15 periodontol probe for pocket&#xD;
      depth and bleeding. A photograph will be taken of the most inflamed side of the implant.&#xD;
      Plaque will be stained with oral hygiene staining rinse and evaluated for Plaque Index.&#xD;
      Finally, a paper strip will be inserted between the gingiva and implant on facial and lingual&#xD;
      sides for 30 seconds each.&#xD;
&#xD;
      GINGIVITIS INDEX: Gingivitis score (GI)= Units on a scale 0 to 3 (0 = no inflammation, 1 =&#xD;
      Mild inflammation slight change in color and little change in texture 2 = Moderate&#xD;
      inflammation moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon&#xD;
      probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous&#xD;
      bleeding. GI scored=sum of GI scores divided by the number of sites (gingival gum line around&#xD;
      the tooth) scored.&#xD;
&#xD;
      PLAQUE INDEX Using Quigley Staining Hein Method with Turesky Modification:Units on a scale 0&#xD;
      to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band&#xD;
      of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two&#xD;
      thirds of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth. Plaque&#xD;
      score = sum of all scores divided by the number of sites (teeth) scored.&#xD;
&#xD;
      Each patients will be instructed to brush around the implant with a pea size amount of&#xD;
      dentifrice provided, twice daily for 30 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 22, 2017</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 15, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective, randomized, controlled, double-blind, single center</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Gels are in coded opaque tubes created at the manufacturer</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Gingival Index</measure>
    <time_frame>30 days</time_frame>
    <description>Level of clinical inflammation around dental implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque Index</measure>
    <time_frame>30 days</time_frame>
    <description>Amount of biofilm around dental implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crevicular Fluid Biomarkers</measure>
    <time_frame>30 days</time_frame>
    <description>Fluid from around implant measured for inflammation markers with ELISA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Mucositis</condition>
  <arm_group>
    <arm_group_label>Livionex gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brushing area of mucositis with Livionex gel for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aquafresh gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brushing area of mucositis with Aquafresh gel for 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Livionex gel</intervention_name>
    <description>Brushing area of mucositis with gel</description>
    <arm_group_label>Livionex gel</arm_group_label>
    <other_name>Aquafresh gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aquafresh gel</intervention_name>
    <description>Aquafresh gel</description>
    <arm_group_label>Aquafresh gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  history of 5 mm+ pocket bleeding on probing around implant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  dental treatment of implant in previous 30 days&#xD;
&#xD;
          -  Sjogrens disease&#xD;
&#xD;
          -  immunodeficiencies (e.g. AIDS)&#xD;
&#xD;
          -  poorly-controlled diabetes&#xD;
&#xD;
          -  regular use of antibiotics, anti-inflammatory drugs or immune suppressants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Nebraska Medical Center College of Dentistry</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68583</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2017</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Richard Reinhardt</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

